# Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study

> **NCT01956305** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 48 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** DS-7309
- **DRUG:** placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01956305
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956305, "Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01956305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*